Bio Essence (BIOE) EBITDA (2020 - 2026)
Bio Essence (BIOE) recorded quarterly EBITDA of $215795.0 in Q1 2026, down 79.04% quarter-over-quarter from $1.0 million in Q4 2025, and up 205.22% on a YoY basis from $70701.8 in Q1 2025.
Bio Essence (BIOE) EBITDA (2020 - 2026) Analysis & Trends
Bio Essence's EBITDA history runs 7 years deep, the most recent figure standing at $215795.0 for Q1 2026.
- In Q1 2026, EBITDA rose 205.22% year-over-year to $215795.0; the TTM figure through Mar 2026 stood at $1.3 million (up 357.64% YoY), while the FY2025 annual figure was $900011.0, up 295.89% from the prior year.
- EBITDA was $215795.0 for Q1 2026 at Bio Essence, down from $1.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $1.0 million in Q4 2025 to a low of -$226432.0 in Q1 2022.
- Historically, EBITDA has averaged -$11785.9 across 5 years, with a median of -$82644.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: EBITDA sank 524.55% in 2024, then surged 26629.67% in 2025.
- A 5-year view of EBITDA shows it stood at $63759.0 in 2022, then slumped by 406.59% to -$195476.0 in 2023, then soared by 101.97% to $3852.0 in 2024, then soared by 26629.67% to $1.0 million in 2025, then plunged by 79.04% to $215795.0 in 2026.
- The last three EBITDA figures came in at $215795.0 (Q1 2026), $1.0 million (Q4 2025), and $14253.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -98.81 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | 215,795.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215,795.00 |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 14,253.00 |
| Jun 30, 2025 | 61,223.00 |
| Mar 31, 2025 | -205,092.00 |
| Dec 31, 2024 | 3,852.00 |
| Sep 30, 2024 | -146,448.00 |
| Jun 30, 2024 | -165,013.00 |
| Mar 31, 2024 | -151,828.00 |
| Dec 31, 2023 | -195,476.00 |
| Sep 30, 2023 | -82,644.00 |
| Jun 30, 2023 | -43,161.00 |
| Mar 31, 2023 | -24,310.00 |
| Dec 31, 2022 | 63,759.00 |
| Sep 30, 2022 | -192,570.00 |
| Jun 30, 2022 | -155,895.00 |
| Mar 31, 2022 | -226,432.00 |
| Dec 31, 2021 | -198,769.00 |
| Sep 30, 2021 | -192,932.00 |
| Jun 30, 2021 | -261,295.00 |